Zacks Research Analysts Decrease Earnings Estimates for EHC

Encompass Health Co. (NYSE:EHC) – Analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for Encompass Health in a note issued to investors on Thursday, February 20th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $1.19 for the quarter, down from their previous forecast of $1.23. The consensus estimate for Encompass Health’s current full-year earnings is $4.80 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.13 EPS, FY2025 earnings at $4.67 EPS, Q1 2026 earnings at $1.30 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.21 EPS, FY2026 earnings at $5.19 EPS and FY2027 earnings at $5.67 EPS.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%.

A number of other equities research analysts also recently commented on the company. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Barclays boosted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. KeyCorp increased their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Down 2.5 %

EHC opened at $97.42 on Monday. The business has a 50 day simple moving average of $95.98 and a 200-day simple moving average of $95.96. Encompass Health has a 12 month low of $73.68 and a 12 month high of $104.55. The stock has a market capitalization of $9.81 billion, a P/E ratio of 21.84, a P/E/G ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Institutional Trading of Encompass Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB lifted its holdings in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. Colonial Trust Co SC purchased a new position in shares of Encompass Health during the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC acquired a new stake in Encompass Health during the third quarter worth approximately $40,000. Transce3nd LLC purchased a new stake in Encompass Health in the 4th quarter worth approximately $40,000. Finally, CBIZ Investment Advisory Services LLC raised its holdings in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.10% of the stock is owned by corporate insiders.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.70%. Encompass Health’s dividend payout ratio is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.